| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11b6b43c7d7f4b33377f6b7a7b4250e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a47f4800cfcbcf07aecbb75de02ceaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eba8f8d7863a0ac6e8b27536c40e12a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_276b867e6f5bb7d8b44cf3e67cba4009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c8f95c962dbea678c1c1cbca1fbdb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_303284ed1a121f13db85872379245a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe77469b50946b08630bcb6003a03d8 |
| publicationDate |
2018-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201828997-A |
| titleOfInvention |
SNAP25 antisense oligonucleotide |
| abstract |
The present invention provides peptide nucleic acid derivatives that target the 3 'splice site of human SNAP25 pre-mRNA. The peptide nucleic acid derivatives strongly induce at least one splice variant of the human SNAP25 mRNA in cells, and can be used to safely treat skin symptoms or conditions involving the expression of human SNAP25 protein by local administration. |
| priorityDate |
2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |